On October 7, 2025, Aimed Alliance sent a follow-up letter to the U.S. Food and Drug Administration (FDA) regarding the…
Aimed Alliance submitted a comment to the Oregon Prescription Drug Affordability Board (PDAB) urging it to maintain a careful, evidence-based…
Prior to the Maryland Prescription Drug Affordability Board’s July meeting to conduct cost affordability reviews for Farxiga and Jardiance, Aimed…
On June 26, 2025, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) on its…
The Inflation Reduction Act (IRA) aimed to lower prescription drug costs by capping annual out-of-pocket spending for Medicare beneficiaries at…
Aimed Alliance sent a letter to Governor Lombardo opposing Nevada Assembly Bill 259, which would cap health plan reimbursement for…
A new analysis from the Pioneer Institute shows that federal price controls under the Inflation Reduction Act (IRA) may be…
Oregon Senator Deb Patterson, Chair of the Senate Health Care Committee, has decided not to introduce a bill this session…
For the second consecutive year, Governor Glenn Youngkin has vetoed legislation aimed at establishing a Prescription Drug Affordability Board (PDAB).…
Aimed Alliance submitted a letter to the Kansas Legislature, urging the Committee on Financial Institutions and Insurance to evaluate the…